Skip to main content
. 2018 Mar 15;19:24. doi: 10.1186/s12910-018-0262-9

Table 7.

Answers to question 8. “How does your institution define “serious harm” as outlined in paragraph 32 of the Declaration of Helsinki for a patient which would restrict the use of placebo?”

Definition of serious harm Country
Persistent or significant disability/incapacity Armenia, Botswana, Germany, Ghana, Japan, Latvia, Malaysia, Namibia, Republic of Belarus, Saudi Arabia, Slovakia, The EU, The Netherlands, USA
Life-threatening events Botswana, Cuba, Czech Republic, Germany, Ghana, Hungary, Israel, Namibia, Republic of Belarus, Saudi Arabia, Tanzania, The EU
Death Botswana, Ghana, Namibia, Republic of Belarus, Saudi Arabia, Tanzania, The EU, USA
Inpatient hospitalization or causes prolongation of existing hospitalization Germany, Ghana, Namibia, Saudi Arabia, The EU, United Arab Emirates
Congenital anomaly/birth defect Germany, Ghana, Namibia, Saudi Arabia,
Requires intervention to prevent permanent impairment or damage Saudi Arabia, The EU
Maintenance therapy for schizophrenic patients Hungary